Julie Veyssiere is a Senior Research Scientist with over 5 years of experience in Safety Assessment, and involvement in development of programs for pharmaceutical and biotechnology products with particular expertise in systemic toxicology and CNS targeted deliveries. Julie is experienced in designing, overseeing, and managing non-clinical safety assessment programs for a wide range of modalities including small molecules, biologics, oligonucleotides, siRNAs, and gene therapies for a broad array of therapeutic indications, including orphan indications.
Lay Proper Toxicology Groundwork for a Successful Preclinical IND Submission
Amid the shifting sands of preclinical drug development, general toxicology research remains the cornerstone of a successful IND program. Your sprint to market requires a solid foundation of informed planning and forward thinking. This webinar delves into the factors to consider when you’re laying the groundwork for your product’s safety profile.
Watch Now